One step closer: a COVID vaccine designed for long lasting immunity Experts say a new vaccine candidate targeting T cells is promising. So what could it mean for the global pandemic response?
COVID immunity following natural infection likely short-lived: Study New research suggests reinfection can occur in as little as three months, strengthening the argument for vaccination.
Research provides hope for ‘Holy Grail’ coronavirus vaccine The antibody response to COVID-19 vaccination among SARS survivors shows there is potential for a powerful new variant-proof vaccine.
Could a pill beat COVID-19? Pfizer is giving it a go While the focus has been largely on vaccines, Pfizer is trialling a pill that directly targets SARS-CoV-2.
Potential COVID treatment reduces viral count in mice lungs by 99.9% And experts believe this form of medicine will translate to similar outcomes in humans, making it a ‘viable therapy’ for COVID-19.
Why are asthma patients not at increased susceptibility to COVID? Researchers believe the answer may relate to reduced expression of ACE-2 receptors in the lower airway.
SARS-CoV-2 surviving 28 days on a surface ‘worst-case scenario’ Given the CSIRO research was conducted in laboratory conditions, scientists note such survival times would not be expected in direct sunlight.
Drive-thru coronavirus testing ‘needs to be explored’: Victorian health chief Victoria’s Chief Health Officer has backed drive-thru coronavirus testing in the event the virus begins spreading widely in Australia.
How does coronavirus compare with previous global outbreaks? Coronavirus – COVID-19 – has infected more than 88,000 people since it was first reported in late December, resulting in at least 3000 deaths.